[HTML][HTML] The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy

B Hou, T Chen, H Zhang, J Li, P Wang… - Frontiers in …, 2023 - frontiersin.org
The tumor microenvironment (TME) is the tumor surrounding environment, which is critical
for tumor development and progression. TME is also involved in clinical intervention and …

[HTML][HTML] Artificial intelligence and precision medicine: a new frontier for the treatment of brain tumors

AK Philip, BA Samuel, S Bhatia, SAM Khalifa… - Life, 2022 - mdpi.com
Brain tumors are a widespread and serious neurological phenomenon that can be life-
threatening. The computing field has allowed for the development of artificial intelligence …

[HTML][HTML] Epigenetic modification regulates tumor progression and metastasis through EMT

T Tan, P Shi, MN Abbas, Y Wang… - International …, 2022 - spandidos-publications.com
Epigenetics is the study of heritable molecular determinants that are independent of
phenotypic features. The epigenetic features include DNA methylation, histone …

Ubiquitin proteasome system in immune regulation and therapeutics

SA Bhat, Z Vasi, R Adhikari, A Gudur, A Ali… - Current opinion in …, 2022 - Elsevier
The ubiquitin proteasome system (UPS) is a proteolytic machinery for the degradation of
protein substrates that are post-translationally conjugated with ubiquitin polymers through …

[HTML][HTML] Targeting ferroptosis by ubiquitin system enzymes: a potential therapeutic strategy in cancer

Y Meng, H Sun, Y Li, S Zhao, J Su, F Zeng… - … Journal of Biological …, 2022 - ncbi.nlm.nih.gov
Ferroptosis is a novel type of regulated cell death driven by the excessive accumulation of
iron-dependent lipid peroxidation. Therapy-resistant tumor cells, particularly those in the …

[HTML][HTML] Macrophages are a double-edged sword: molecular crosstalk between tumor-associated macrophages and cancer stem cells

S Luo, G Yang, P Ye, N Cao, X Chi, WH Yang, X Yan - Biomolecules, 2022 - mdpi.com
Cancer stem cells (CSCs) are a subset of highly tumorigenic cells in tumors. They have
enhanced self-renewal properties, are usually chemo-radioresistant, and can promote tumor …

Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies

S Najafi, K Mortezaee - Life Sciences, 2023 - Elsevier
Chimeric antigen receptor-modified T (CAR-T) are genetically engineered cells to express
tumor-specific antigens revolutionizing the treatment of hematologic malignancies. The …

Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications

Q Li, L Zhou, S Qin, Z Huang, B Li, R Liu… - European Journal of …, 2023 - Elsevier
The success of inhibitor-based therapeutics is largely constrained by the acquisition of
therapeutic resistance, which is partially driven by the undruggable proteome. The …

[HTML][HTML] Exploiting autophagy-dependent neoantigen presentation in tumor microenvironment

E Koustas, EM Trifylli, P Sarantis, N Papadopoulos… - Genes, 2023 - mdpi.com
Autophagy constitutes a well-known homeostatic and catabolic process that is responsible
for degradation and recycling of cellular components. It is a key regulatory mechanism for …

[HTML][HTML] An integrative pan-cancer analysis revealing the difference in small ring finger family of SCF E3 ubiquitin ligases

T Huang, J Li, X Liu, B Shi, S Li, HX An - Frontiers in immunology, 2022 - frontiersin.org
Background The SCF (Skp1-cullin-F-box proteins) complex is the largest family of E3
ubiquitin ligases that mediate multiple specific substrate proteins degradation. Two ring …